The Management of Classical Hodgkin's Lymphoma: Past, Present, and Future

Table 8

Registry data of outcomes of myeloablative allogeneic transplants in relapsed and refractory Hodgkin’s lymphoma. Abbreviations: Sib/UD: Sibling/unrelated donor; PFS: progression-free survival; OS: overall survival; TRM: treatment-related mortality; IBMTR: International bone marrow transplant registry; EBMT: European Group for Blood and Marrow Transplantation; FHCRC: Fred Hutchinson Cancer Research Center; JHOC: Johns Hopkins Oncology Center.

Study; (group, author)	No. of pts	Sib/UD	Median age; (range)	PFS; (%, years)	OS (%)	TRM (%)
IBMTR	100	100	28	15 (3 y)	21	61
(Gajewski 1996)			(12–44)
EBMT	45	45	29	15 (4 y)	25	48
(Milpied 1996)			(15–42)
FHCRC	53	50/3	29	18 (5 y)	21	49
(Anderson 1993)			(10–55)
JHOC	53	53	28	26 (10 y)	30	43 (total)
(Akpek 2001)			(13–52)
EBMT	167	145/12	24	16 (4 y)	25	52
(Peniket 2003)			(7–57)